Krystal Biotech Inc. Revenue 2020–2025
Krystal Biotech Inc. annual/quarterly revenue history and growth rate from 2020 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Krystal Biotech Inc. revenue for the quarter ending March 31, 2026 was 116.4 M, a 31.95% increase year-over-year.
- Krystal Biotech Inc. revenue for the twelve months ending March 31, 2026 was 417.3 M.
- Krystal Biotech Inc. annual revenue for 2025 was 389.1 M, a 33.94% increase from 2024.
- Krystal Biotech Inc. annual revenue for 2024 was 290.5 M, a 473.02% increase from 2023.
- Krystal Biotech Inc. annual revenue for 2023 was 50.7 M.
- Krystal Biotech Inc. annual revenue for 2022 was 0.
Krystal Biotech Inc. (KRYS) — Frequently Asked Questions
Krystal Biotech Inc. (KRYS) is a publicly traded US company. It has a market capitalization of $9.04B. In fiscal 2025 it reported revenue of $389M and net income of $205M. Explore KRYS's stock price, financial statements, earnings history, margins and key ratios below.
What is Krystal Biotech Inc.'s market cap?
Krystal Biotech Inc. (KRYS) has a market capitalization of $9.04B.
What is the KRYS stock price?
KRYS trades at $312.41 (+0.86% on the day).
How much revenue does Krystal Biotech Inc. make?
Krystal Biotech Inc. reported revenue of $389M in fiscal 2025.
Is KRYS profitable?
In fiscal 2025, Krystal Biotech Inc. reported net income of $205M.
What is KRYS's P/E ratio?
Based on diluted EPS, KRYS has a price-to-earnings (P/E) ratio of about 45.7.